Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T‐rich phosphorothiate oligodeoxynucleotides

Abstract

Toll‐like receptors (TLR) 7 and 8 are closely related members of the TLR family of pathogen‐associated molecular pattern recognition receptors and have an important function in activation of innate immune responses upon viral infection. TLR7 can be activated selectively by the guanosine analogue loxoribine, whereas the imidazoquinoline derivative Resiquimod (R‐848) activates both TLR7 and TLR8. We demonstrate that co‐incubation of R‐848 with thymidine homopolymer oligodeoxynucleotides (ODN) significantly increased activity of R‐848 on TLR8‐expressing HEK 293 cells, but abolished TLR7‐mediated signaling. Similarly, the combination of loxoribine and thymidine ODN redirected the stimulatory effect of loxoribine away from TLR7, and toward TLR8. This alteration in ligand specificity was demonstrated both in TLR‐transfected HEK cells, and also in human PBMC, with a corresponding change in cytokine production away from IFN‐α secretion by TLR7‐expressing plasmacytoid DC and toward IL‐12, TNF‐α and IFN‐γ secretion by TLR8‐expressing monocytes and NK cells. These results demonstrate an unexpected plasticity in the ligand specificities of TLR7 and TLR8, and suggest a novel sequence‐selective interaction between these receptors and synthetic phosphorothioate ODN.